Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Many patients with hypertrophic cardiomyopathynever need treatment. However, it is imperative for all patients to be monitored by a cardiologist. A cardiologist will work with the patient to determine an individualized plan for monitoring, medical therapy, intervention and follow-up.
The patient will communicate with the healthcare provider to determine treatment options based on factors such as:
Extent of the disease
Tolerance for specific medications, procedures, or therapies
Expectations for the course of the disease
Learn more about the following treatment options for hypertrophic cardiomyopathy:
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.